Corton Capital’s ResMed RMD Stock Holding History

Corton Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,860	Closed	-$425K	–	372
2024 Q4	$425K	Buy	+1,860	New	+$448K	0.24%	30
2024 Q3	–	Sell	-2,077	Closed	-$398K	–	639
2024 Q2	$398K	Buy	+2,077	New	+$421K	0.21%	99
2023 Q4	–	Sell	-1,573	Closed	-$233K	–	638
2023 Q3	$233K	Buy	+1,573	New	+$284K	0.12%	265

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Corton Capital's RMD Position: Q1 2025 in Review

Corton Capital sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,860 shares — an estimated $425K sold.

Corton Capital first reported a position in RMD in Q3 2023 and held it in 3 quarters. The position peaked at $425K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Corton Capital reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Corton Capital sold 1,860 ResMed shares in Q1 2025, an estimated $425K.
Corton Capital first reported a position in ResMed in Q3 2023 and held it in 3 quarters.
Corton Capital's ResMed position peaked at $425K in Q4 2024.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.